MedTrace Logo

Prehospital High-Flow Nasal Oxygen Therapy

NCT03326830 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2023-02-17

No results posted yet for this study

Summary

The purpose of the present project is to compare High-Flow Nasal Oxygen therapy with Standard Oxygen therapy, initiated in the prehospital setting in patients with acute hypoxemia respiratory failure, in terms of oxygenation at arrival to the hospital and need of mechanical ventilation during the subsequent 28 days

Conditions

  • Acute Respiratory Failure With Hypoxia
  • Oxygen Inhalation Therapy
  • Prehospital Setting

Interventions

DEVICE

High-flow nasal oxygen

oxygen therapy will be delivered through a dedicated system, the Airvo2™ (Fisher\&Paykel, New-Zealand).

DEVICE

Standard oxygen therapy

Oxygen therapy will be delivered using standard devices such as nasal canula or face mask with or without rebreathing bag

Sponsors & Collaborators

  • Centre Hospitalier Régional d'Orléans

    lead OTHER

Principal Investigators

  • Mai-Anh Nay, MD · Centre Hospitalier Régional d'Orléans

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-21
Primary Completion
2022-08-10
Completion
2022-08-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03326830 on ClinicalTrials.gov